CN111557892A - 含益生元的化妆品组合物 - Google Patents
含益生元的化妆品组合物 Download PDFInfo
- Publication number
- CN111557892A CN111557892A CN202010305309.7A CN202010305309A CN111557892A CN 111557892 A CN111557892 A CN 111557892A CN 202010305309 A CN202010305309 A CN 202010305309A CN 111557892 A CN111557892 A CN 111557892A
- Authority
- CN
- China
- Prior art keywords
- parts
- cosmetic composition
- glycerol
- acid
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 239000002537 cosmetic Substances 0.000 title claims abstract description 43
- 235000013406 prebiotics Nutrition 0.000 title claims abstract description 33
- 239000000284 extract Substances 0.000 claims abstract description 40
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 claims abstract description 21
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229940124277 aminobutyric acid Drugs 0.000 claims abstract description 21
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 21
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229940071085 lauroyl glutamate Drugs 0.000 claims abstract description 21
- 239000012138 yeast extract Substances 0.000 claims abstract description 21
- 244000068988 Glycine max Species 0.000 claims abstract description 20
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 20
- GOVINWHEYOSPAK-GPOMZPHUSA-N hexadecyl (2s,4r)-1-hexadecanoyl-4-hydroxypyrrolidine-2-carboxylate Chemical class CCCCCCCCCCCCCCCCOC(=O)[C@@H]1C[C@@H](O)CN1C(=O)CCCCCCCCCCCCCCC GOVINWHEYOSPAK-GPOMZPHUSA-N 0.000 claims abstract description 17
- IHRKJQSLKLYWBQ-QKDODKLFSA-N (2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[2-(hexadecanoylamino)acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O IHRKJQSLKLYWBQ-QKDODKLFSA-N 0.000 claims abstract description 5
- 229940094946 palmitoyl tetrapeptide-7 Drugs 0.000 claims abstract description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 117
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 36
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 36
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 36
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 36
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 36
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 29
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 claims description 26
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 24
- 229920002125 Sokalan® Polymers 0.000 claims description 24
- 229960001631 carbomer Drugs 0.000 claims description 24
- 239000000230 xanthan gum Substances 0.000 claims description 24
- 229920001285 xanthan gum Polymers 0.000 claims description 24
- 229940082509 xanthan gum Drugs 0.000 claims description 24
- 235000010493 xanthan gum Nutrition 0.000 claims description 24
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 20
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 19
- 239000002253 acid Substances 0.000 claims description 19
- 229960005323 phenoxyethanol Drugs 0.000 claims description 19
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 claims description 18
- 229920002126 Acrylic acid copolymer Polymers 0.000 claims description 18
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 18
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 18
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 18
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 18
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 18
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 18
- 229960000458 allantoin Drugs 0.000 claims description 18
- 229960003237 betaine Drugs 0.000 claims description 18
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 18
- 235000018417 cysteine Nutrition 0.000 claims description 18
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 18
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 18
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 18
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 18
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 18
- 229940101267 panthenol Drugs 0.000 claims description 18
- 235000020957 pantothenol Nutrition 0.000 claims description 18
- 239000011619 pantothenol Substances 0.000 claims description 18
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 18
- 229940032094 squalane Drugs 0.000 claims description 18
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 18
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 17
- 235000012550 Pimpinella anisum Nutrition 0.000 claims description 17
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 17
- -1 polydimethylsiloxane Polymers 0.000 claims description 17
- 229920000570 polyether Polymers 0.000 claims description 17
- 229920000223 polyglycerol Polymers 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 13
- VKIJBOMCWLTQBD-UHFFFAOYSA-N benzoic acid N-(2-hydroxyphenyl)propanamide Chemical compound C(C1=CC=CC=C1)(=O)O.C(CC)(=O)NC1=C(C=CC=C1)O VKIJBOMCWLTQBD-UHFFFAOYSA-N 0.000 claims description 12
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 11
- 235000012907 honey Nutrition 0.000 claims description 11
- 229960002446 octanoic acid Drugs 0.000 claims description 11
- MFYAQFYIDXXKQG-MLCQCVOFSA-N (2s)-2-[[(2s)-4-amino-2-[[(2s)-2-[[(2s)-2-(hexadecanoylamino)-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]propanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O MFYAQFYIDXXKQG-MLCQCVOFSA-N 0.000 claims description 8
- 108010075308 N-palmitoyl-seryl-seryl-asparaginyl-alanine Proteins 0.000 claims description 8
- 238000007599 discharging Methods 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 150000003863 ammonium salts Chemical group 0.000 claims description 6
- KIUVQMGRTDPAFR-UHFFFAOYSA-N benzoic acid 2-hydroxy-2-phenylpropanamide Chemical compound C(C1=CC=CC=C1)(=O)O.OC(C(=O)N)(C)C1=CC=CC=C1 KIUVQMGRTDPAFR-UHFFFAOYSA-N 0.000 claims description 6
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 claims description 5
- 229940060384 isostearyl isostearate Drugs 0.000 claims description 5
- NSNRBCFTRWSAAQ-BLPFIKBVSA-N C(CCCCCCCCCCCCCCC)[C@@]1(N(C[C@@H](C1)O)C(CCCCCCCCCCCCCCC)=O)C(=O)O Chemical compound C(CCCCCCCCCCCCCCC)[C@@]1(N(C[C@@H](C1)O)C(CCCCCCCCCCCCCCC)=O)C(=O)O NSNRBCFTRWSAAQ-BLPFIKBVSA-N 0.000 claims description 4
- 150000002333 glycines Chemical class 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- 229940008099 dimethicone Drugs 0.000 claims description 2
- 229960005150 glycerol Drugs 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 240000009023 Myrrhis odorata Species 0.000 claims 4
- 239000002304 perfume Substances 0.000 claims 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 8
- 230000002087 whitening effect Effects 0.000 abstract description 5
- 230000032683 aging Effects 0.000 abstract description 4
- 230000003020 moisturizing effect Effects 0.000 abstract description 4
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 3
- 230000037067 skin hydration Effects 0.000 abstract description 3
- 230000037303 wrinkles Effects 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 241001534815 Hypsizygus marmoreus Species 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 description 31
- 210000003491 skin Anatomy 0.000 description 22
- 230000000052 comparative effect Effects 0.000 description 15
- 240000004760 Pimpinella anisum Species 0.000 description 13
- 230000004888 barrier function Effects 0.000 description 9
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 230000008591 skin barrier function Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YEYKMVJDLWJFOA-UHFFFAOYSA-N 2-propoxyethanol Chemical compound CCCOCCO YEYKMVJDLWJFOA-UHFFFAOYSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- 241001537183 Hypecoum Species 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 229920000289 Polyquaternium Polymers 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- HPZJMUBDEAMBFI-WTNAPCKOSA-N (D-Ala(2)-mephe(4)-gly-ol(5))enkephalin Chemical compound C([C@H](N)C(=O)N[C@H](C)C(=O)NCC(=O)N(C)[C@@H](CC=1C=CC=CC=1)C(=O)NCCO)C1=CC=C(O)C=C1 HPZJMUBDEAMBFI-WTNAPCKOSA-N 0.000 description 1
- QXZJDGNHGLPKQB-UHFFFAOYSA-N 2-(2-hydroxypropoxy)propan-1-ol prop-1-ene Chemical compound CC(COC(C)CO)O.C=CC.C=CC QXZJDGNHGLPKQB-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- NCYDRNOBBHFJHE-UHFFFAOYSA-N propane-1,2-diol;prop-1-ene Chemical compound CC=C.CC(O)CO NCYDRNOBBHFJHE-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229960004747 ubidecarenone Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了含益生元的化妆品组合物,通过特定的配方,将海茴香提取物、野大豆籽提取物、N‑棕榈酰羟基脯氨酸鲸蜡酯、植物甾醇/辛基十二醇月桂酰谷氨酸酯、氨基丁酸、棕榈酰四肽‑7、水解酵母提取物进行复配,制备得到的护肤品具有修护、抗皱抗衰、保湿、抗炎、美白等功效,能够使得皮肤看起来更光滑、更健康以及年轻,长期使用有效维持皮肤水润、饱满。而且,本发明护肤品的抗氧活性更高,肤色L更高使得皮肤透亮度更强,皮肤水合度更强。
Description
技术领域
本发明属于化妆品领域,特别涉及含益生元的化妆品组合物。
背景技术
人体肌肤表层有六大防护屏障,包括渗透屏障、化学物质屏障、刺激屏障、自由基屏障、机械力屏障和免疫屏障。但是现在生活压力、饮食以及外界环境都有可能造成皮肤屏障受损,减弱肌肤防护屏障。拥有健康的皮肤屏障,能够抵御外界有害物、刺激物和日光的影响,以及拥有保湿及调节作用。如何找到一种使用安全、有效恢复皮肤屏障的产品成为日益严峻的问题。
发明内容
本发明的目的在于提供含益生元的化妆品组合物。
本发明所采取的技术方案是:
本发明第一方面,提供了含益生元的化妆品组合物,包含以下组分:
A.尿囊素、甘草酸二钾、甜菜碱、聚甘油、甘油聚醚、甘油、卡波姆、黄原胶、野大豆籽提取物、甘油丙烯酸酯/丙烯酸共聚物;
B.辛酸/癸酸甘油三酯、聚二甲基硅氧烷、N-棕榈酰羟基脯氨酸鲸蜡酯、角鲨烷、异硬脂醇异硬脂酸酯、植物甾醇/辛基十二醇月桂酰谷氨酸酯、海茴香提取物;
C.三乙醇胺;
D.氨基丁酸;
E.透明质酸钠、丁二醇、透明质酸钠、棕榈酰四肽-7、羟苯基丙酰胺苯甲酸、半胱氨酸、泛醇、聚季铵盐-51、水解酵母提取物;
F.香精;
G.辛酰羟肟酸、苯氧乙醇。
根据本发明的实施例,还包括水。
根据本发明的实施例,包含以下重量份的组分:
A.尿囊素0.05~0.3份、甘草酸二钾0.05~0.3份、甜菜碱0.5~3份、聚甘油1~4份、甘油聚醚0.5~3份、甘油2~5份、卡波姆8~13份、黄原胶6~10份、野大豆籽提取物0.5~2.5份、甘油丙烯酸酯/丙烯酸共聚物0.2~1份;
B.辛酸/癸酸甘油三酯1~5份、聚二甲基硅氧烷0.5~3.5份、N-棕榈酰羟基脯氨酸鲸蜡酯0.1~1.5份、角鲨烷0.1~1份、异硬脂醇异硬脂酸酯0.2~0.9份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.1~1.5份、海茴香提取物0.1~1份;
C.三乙醇胺0.1~0.5份;
D.氨基丁酸0.05~0.85份;
E.透明质酸钠0.01~0.09份、丁二醇0.1~0.4份、透明质酸钠0.01~0.06份、棕榈酰四肽-7 0.1~0.9份、羟苯基丙酰胺苯甲酸0.1~0.6份、半胱氨酸0.5~3份、泛醇0.1~1份、聚季铵盐-51 0.1~0.8份、水解酵母提取物0.5~2份;
F.香精0.018~0.058份;
G.辛酰羟肟酸0.1~0.8份、苯氧乙醇0.1~0.5份。
根据本发明的实施例,包含以下重量份的组分:
A.尿囊素0.05~0.15份、甘草酸二钾0.05~0.25份、甜菜碱1~2份、聚甘油1~3份、甘油聚醚0.5~1.5份、甘油2~3份、卡波姆8~10份、黄原胶6~8份、野大豆籽提取物0.5~1.5份、甘油丙烯酸酯/丙烯酸共聚物0.5~1份;
B.辛酸/癸酸甘油三酯1~2份、聚二甲基硅氧烷0.5~1.5份、N-棕榈酰羟基脯氨酸鲸蜡酯0.3~0.9份、角鲨烷0.1~0.5份、异硬脂醇异硬脂酸酯0.2~0.5份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.1~0.2份、海茴香提取物0.1~0.5份;
C.三乙醇胺0.16~0.36份;
D.氨基丁酸0.1~0.3份;
E.透明质酸钠0.01~0.03份、丁二醇0.18~0.28份、透明质酸钠0.01~0.03份、棕榈酰四肽-7 0.1~0.5份、羟苯基丙酰胺苯甲酸0.15~0.35份、半胱氨酸0.5~1份、泛醇0.1~0.2份、聚季铵盐-51 0.1~0.3份、水解酵母提取物0.5~1份;
F.香精0.018~0.028份;
G.辛酰羟肟酸0.1~0.5份、苯氧乙醇0.1~0.2份。
根据本发明的实施例,包含以下重量份的组分:
A.尿囊素0.1份、甘草酸二钾0.1份、甜菜碱1份、聚甘油2份、甘油聚醚1份、甘油3份、卡波姆10份、黄原胶8份、野大豆籽提取物1份、甘油丙烯酸酯/丙烯酸共聚物0.5份;
B.辛酸/癸酸甘油三酯2份、聚二甲基硅氧烷1份、N-棕榈酰羟基脯氨酸鲸蜡酯0.3份、角鲨烷0.1份、异硬脂醇异硬脂酸酯0.5份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.2份、海茴香提取物0.1份;
C.三乙醇胺0.16份;
D.氨基丁酸0.1份;
E.透明质酸钠0.03份、丁二醇0.18份、透明质酸钠0.02份、棕榈酰四肽-7 0.5份、羟苯基丙酰胺苯甲酸0.15份、半胱氨酸1份、泛醇0.2份、聚季铵盐-51 0.2份、水解酵母提取物1份;
F.香精0.028份;
G.辛酰羟肟酸0.5份、苯氧乙醇0.2份。
根据本发明的实施例,A组分所述聚甘油为聚甘油-6。
根据本发明的实施例,A组分所述甘油聚醚为甘油聚醚-26。
根据本发明的实施例,A组分所述卡波姆为2~3%卡波姆;所述黄原胶为2~3%黄原胶。
根据本发明的实施例,F组分所述香精包括TAIFEX 3465香精、ALINE CO 12838香精和HONEY FLAVOUR DC5023/01香精。
本发明第二方面,提供了前面任一所述含益生元的化妆品组合物的制备方法,包括以下步骤:按照任一所述组分进行称取,并分别混合成A、B、C、D、E、F和G组分,搅拌混匀,出料,即可得到含益生元的化妆品组合物。
本发明使用的海茴香提取物在所有浓度下的抗氧活性均高于α-生育酚和BHT,能抑制亚油酸的过氧化作用。同时能抑制酪氨酸酶的活性,具有美白的功效。
野大豆籽提取物,购自lysofix,英文名称是GLYCINE SOJA(SOYBEAN)SEEDEXTRACT,主要作用是抗氧化剂,保湿剂,风险系数为1,安全性高。从野大豆的籽粒中提取的纯天然产物,含有丰富的黄酮等成分,能够促进纤维芽细胞的生长,具有活肤,抗衰老的作用;同时能保持皮肤的水分,有保湿功效。
N-棕榈酰羟基脯氨酸鲸蜡酯,是一种类神经酰胺衍生物。具有保护皮肤,维持皮肤屏障功能,对抗过多的水分流失;增加表皮角质层厚度,增加皮肤弹性,延缓皮肤衰老;抑止有害物质的侵入,避免皮肤过敏;增强角化细胞之间粘着力,改善皮肤干燥、脱屑、粗糙等症状。
植物甾醇/辛基十二醇月桂酰谷氨酸酯,英文名称是PHYTOSTERYL/OCTYLDODECYLLAUROYL GLUTAMATE,在化妆品、护肤品里主要作用是柔润剂,风险系数为1,比较安全,可以放心使用。它来源于天然脂肪酸的谷氨酸和植物甾醇的润肤剂。研究证明,其可像神经酰胺一样形成液态晶体薄膜。因此,其润肤性可同神经酰胺相媲美。它天然,温和,环保。具有柔润肌肤的作用。
氨基丁酸,化妆品中主要用其细胞复活作用。可与多种活性物配伍并提高它们的药效:如与亚麻酸配伍可作护肤调理剂;与维生素Q配伍有协同抗老化效应;能有效增强生发助剂如甲氰咪胺、榔色木酸的功能;用于洗发水也有抑制酪氨酸酶作用。可与抗氧剂及紫外吸收剂共用于增白型化妆品。
棕榈酰四肽-7能帮助促进胶原蛋白生成的多肽类成分,缓解细纹皱纹。
本发明化妆品组合的益生元,益生元主要成分指的是二裂酵母发酵产物溶胞物(又称水解酵母提取物)。
而水解酵母提取物,在皮肤蛋白的角蛋白生成中维持重要的琉基酶的活性,并且补充硫基,以维持皮肤的正常代谢,调节表皮最下层的色素细胞生成的底层黑色素,是种非常理想的自然美白化妆品。它可以除去皮肤本身的黑色素,改变皮肤本身的性质,使皮肤变得自然的美白。具有防止生物体衰老的功能。
本发明使用的组成及其商品名如下。
表1
本发明的有益效果是:
本发明通过特定的配方,将海茴香提取物、野大豆籽提取物、N-棕榈酰羟基脯氨酸鲸蜡酯、植物甾醇/辛基十二醇月桂酰谷氨酸酯、氨基丁酸、棕榈酰四肽-7、水解酵母提取物进行复配,制备得到的护肤品具有修护、抗皱抗衰、保湿、抗炎、美白等功效,能够使得皮肤看起来更光滑、更健康以及年轻。通过实验研究证明,本发明护肤品的抗氧活性更高,肤色L更高使得皮肤透亮度更强,皮肤水合度更强。
具体实施方式
下面结合实施例对本发明中的技术方案进行清楚、完整的说明,但并不局限于此。
实施例1
含益生元的化妆品组合物,包含以下组分:
A.尿囊素0.05份、甘草酸二钾0.05份、甜菜碱1份、聚甘油-6 1份、甘油聚醚-260.5份、甘油2份、2%卡波姆8份、2%黄原胶6份、野大豆籽提取物0.5份、甘油丙烯酸酯/丙烯酸共聚物0.5份;
B.辛酸/癸酸甘油三酯1份、聚二甲基硅氧烷0.5份、N-棕榈酰羟基脯氨酸鲸蜡酯0.3份、角鲨烷0.1份、异硬脂醇异硬脂酸酯0.2份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.1份、海茴香提取物0.1份;
C.三乙醇胺0.16份;
D.氨基丁酸0.1份;
E.(HA-TP)130-150万中分子透明质酸钠0.01份、丁二醇0.18份、(纳诺HA)3000-1万低分子透明质酸钠0.01份、棕榈酰四肽-7 0.1份、羟苯基丙酰胺苯甲酸0.15份、半胱氨酸0.5份、泛醇0.1份、聚季铵盐-51 0.1份、水解酵母提取物0.5份;
F.TAIFEX 3465香精0.002份、ALINE CO 12838香精0.01份、HONEY FLAVOURDC5023/01香精0.006份;
G.辛酰羟肟酸0.1份、苯氧乙醇0.1份;
纯化水余量。
制备方法,按照任一所述组分进行称取,并分别混合成A、B、C、D、E、F和G组分,搅拌混匀,出料,即可得到含益生元的化妆品组合物。
实施例2
含益生元的化妆品组合物,包含以下组分:
A.尿囊素0.15份、甘草酸二钾0.25份、甜菜碱2份、聚甘油-6 3份、甘油聚醚-261.5份、甘油3份、2%卡波姆10份、2%黄原胶8份、野大豆籽提取物1.5份、甘油丙烯酸酯/丙烯酸共聚物1份;
B.辛酸/癸酸甘油三酯2份、聚二甲基硅氧烷1.5份、N-棕榈酰羟基脯氨酸鲸蜡酯0.9份、角鲨烷0.5份、异硬脂醇异硬脂酸酯0.5份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.2份、海茴香提取物0.5份;
C.三乙醇胺0.36份;
D.氨基丁酸0.3份;
E.(HA-TP)130-150万中分子透明质酸钠0.03份、丁二醇0.28份、(纳诺HA)3000-1万低分子透明质酸钠0.03份、棕榈酰四肽-7 0.5份、羟苯基丙酰胺苯甲酸0.35份、半胱氨酸1份、泛醇0.2份、聚季铵盐-51 0.3份、水解酵母提取物1份;
F.TAIFEX 3465香精0.022份、ALINE CO 12838香精0.03份、HONEY FLAVOURDC5023/01香精0.006份;
G.辛酰羟肟酸0.5份、苯氧乙醇0.2份;纯化水余量。
制备方法,按照任一所述组分进行称取,并分别混合成A、B、C、D、E、F和G组分,搅拌混匀,出料,即可得到含益生元的化妆品组合物。
实施例3
含益生元的化妆品组合物,包含以下组分:
A.尿囊素0.05份、甘草酸二钾0.05份、甜菜碱2份、聚甘油-6 1份、甘油聚醚-260.5份、甘油2份、2%卡波姆8份、2%黄原胶8份、野大豆籽提取物0.5份、甘油丙烯酸酯/丙烯酸共聚物0.5份;
B.辛酸/癸酸甘油三酯1份、聚二甲基硅氧烷0.5份、N-棕榈酰羟基脯氨酸鲸蜡酯0.3份、角鲨烷0.1份、异硬脂醇异硬脂酸酯0.2份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.1份、海茴香提取物0.1份;
C.三乙醇胺0.16份;
D.氨基丁酸0.1份;
E.(HA-TP)130-150万中分子透明质酸钠0.01份、丁二醇0.18份、(纳诺HA)3000-1万低分子透明质酸钠0.01份、棕榈酰四肽-7 0.1份、羟苯基丙酰胺苯甲酸0.15份、半胱氨酸0.5份、泛醇0.1份、聚季铵盐-51 0.1份、水解酵母提取物0.5份;
F.TAIFEX 3465香精0.002份、ALINE CO 12838香精0.01份、HONEY FLAVOURDC5023/01香精0.006份;
G.辛酰羟肟酸0.1份、苯氧乙醇0.1份;
纯化水余量。
制备方法,按照任一所述组分进行称取,并分别混合成A、B、C、D、E、F和G组分,搅拌混匀,出料,即可得到含益生元的化妆品组合物。
实施例4
含益生元的化妆品组合物,包含以下组分:
A.尿囊素0.15份、甘草酸二钾0.25份、甜菜碱2份、聚甘油-6 3份、甘油聚醚-260.5份、甘油3份、2%卡波姆10份、3%黄原胶8份、野大豆籽提取物1.5份、甘油丙烯酸酯/丙烯酸共聚物1份;
B.辛酸/癸酸甘油三酯2份、聚二甲基硅氧烷1.5份、N-棕榈酰羟基脯氨酸鲸蜡酯0.9份、角鲨烷0.5份、异硬脂醇异硬脂酸酯0.5份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.2份、海茴香提取物0.5份;
C.三乙醇胺0.36份;
D.氨基丁酸0.3份;
E.(HA-TP)130-150万中分子透明质酸钠0.03份、丁二醇0.28份、(纳诺HA)3000-1万低分子透明质酸钠0.03份、棕榈酰四肽-7 0.5份、羟苯基丙酰胺苯甲酸0.35份、半胱氨酸1份、泛醇0.2份、聚季铵盐-51 0.3份、水解酵母提取物1份;
F.TAIFEX 3465香精0.012份、ALINE CO 12838香精0.01份、HONEY FLAVOURDC5023/01香精0.006份;
G.辛酰羟肟酸0.5份、苯氧乙醇0.2份;纯化水余量。
制备方法,按照任一所述组分进行称取,并分别混合成A、B、C、D、E、F和G组分,搅拌混匀,出料,即可得到含益生元的化妆品组合物。
实施例5
含益生元的化妆品组合物,包含以下组分:
A.尿囊素0.1份、甘草酸二钾0.1份、甜菜碱1份、聚甘油-6 2份、甘油聚醚-26 1份、甘油3份、3%卡波姆10份、2%黄原胶8份、野大豆籽提取物1份、甘油丙烯酸酯/丙烯酸共聚物0.5份;
B.辛酸/癸酸甘油三酯2份、聚二甲基硅氧烷1份、N-棕榈酰羟基脯氨酸鲸蜡酯0.3份、角鲨烷0.1份、异硬脂醇异硬脂酸酯0.5份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.2份、海茴香提取物0.1份;
C.三乙醇胺0.16份;
D.氨基丁酸0.1份;
E.(HA-TP)130-150万中分子透明质酸钠0.03份、丁二醇0.18份、(纳诺HA)3000-1万低分子透明质酸钠0.02份、棕榈酰四肽-7 0.5份、羟苯基丙酰胺苯甲酸0.15份、半胱氨酸1份、泛醇0.2份、聚季铵盐-51 0.2份、水解酵母提取物1份;
F.TAIFEX 3465香精0.012份、ALINE CO 12838香精0.01份、HONEYFLAVOURDC5023/01香精0.006份;
G.辛酰羟肟酸0.5份、苯氧乙醇0.2份;
纯化水余量。
制备方法,按照任一所述组分进行称取,并分别混合成A、B、C、D、E、F和G组分,搅拌混匀,出料,即可得到含益生元的化妆品组合物。
实施例6
含益生元的化妆品组合物,包含以下组分:
A.尿囊素0.15份、甘草酸二钾0.15份、甜菜碱1.5份、聚甘油-6 2.5份、甘油聚醚-26 1.5份、甘油3.5份、2%卡波姆10.5份、2%黄原胶8.5份、野大豆籽提取物1.5份、甘油丙烯酸酯/丙烯酸共聚物1份;
B.辛酸/癸酸甘油三酯2.5份、聚二甲基硅氧烷1.5份、N-棕榈酰羟基脯氨酸鲸蜡酯0.4份、角鲨烷0.2份、异硬脂醇异硬脂酸酯0.6份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.3份、海茴香提取物0.2份;
C.三乙醇胺0.26份;
D.氨基丁酸0.2份;
E.(HA-TP)130-150万中分子透明质酸钠0.05份、丁二醇0.2份、(纳诺HA)3000-1万低分子透明质酸钠0.04份、棕榈酰四肽-7 0.4份、羟苯基丙酰胺苯甲酸0.25份、半胱氨酸1.5份、泛醇0.4份、聚季铵盐-51 0.3份、水解酵母提取物2份;
F.TAIFEX 3465香精0.015份、ALINE CO 12838香精0.01份、HONEY FLAVOURDC5023/01香精0.009份;
G.辛酰羟肟酸0.6份、苯氧乙醇0.3份;
纯化水余量。
制备方法,按照任一所述组分进行称取,并分别混合成A、B、C、D、E、F和G组分,搅拌混匀,出料,即可得到含益生元的化妆品组合物。
对比例1
化妆品组合物,包含以下组分:RTH007卡波姆CARBOMER 1.6份、ROT021水AQUA88.4份、RMO009丁二醇BUTYLENE GLYCOL 2份、RMO016丙二醇PROPYLENE GLYCOL 2份、RMO004双丙甘醇DIPROPYLENE GLYCOL 3.4份、RMO015甘油GLYCERIN 2份、RPV013苯氧乙醇PHENOXYETHANOL 0.4份、RMO050辛甘醇CAPRYLYL GLYCOL 0.2份。
对比例2
化妆品组合物,包含以下组分:RTH031黄原胶XANTHAN GUM 2份、RMO009丁二醇
BUTYLENE GLYCOL 2份、RMO016丙二醇PROPYLENE GLYCOL 2份、RMO004双丙甘醇DIPROPYLENE GLYCOL 3.4份、RMO015甘油GLYCERIN 2份、RPV013苯氧乙醇PHENOXYETHANOL0.4份、RMO050辛甘醇CAPRYLYL GLYCOL 0.2份、ROT021水
AQUA88份。
对比例3
化妆品组合物,包含以下组分:A.尿囊素0.1份、甘草酸二钾0.1份、甜菜碱1份、聚甘油-6 2份、甘油聚醚-26 1份、甘油3份、3%卡波姆10份、2%黄原胶8份、甘油丙烯酸酯/丙烯酸共聚物0.5份;
B.辛酸/癸酸甘油三酯2份、聚二甲基硅氧烷1份、N-棕榈酰羟基脯氨酸鲸蜡酯0.3份、角鲨烷0.1份、异硬脂醇异硬脂酸酯0.5份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.2份、海茴香提取物0.1份;
C.三乙醇胺0.16份;
D.氨基丁酸0.1份;
E.(HA-TP)130-150万中分子透明质酸钠0.03份、丁二醇0.18份、(纳诺HA)3000-1万低分子透明质酸钠0.02份、棕榈酰四肽-7 0.5份、羟苯基丙酰胺苯甲酸0.15份、半胱氨酸1份、泛醇0.2份、聚季铵盐-51 0.2份、水解酵母提取物1份;
F.TAIFEX 3465香精0.012份、ALINE CO 12838香精0.01份、HONEY FLAVOURDC5023/01香精0.006份;
G.辛酰羟肟酸0.5份、苯氧乙醇0.2份;
纯化水余量。
对比例4
化妆品组合物,包含以下组分:A.尿囊素0.1份、甘草酸二钾0.1份、甜菜碱1份、聚甘油-6 2份、甘油聚醚-26 1份、甘油3份、3%卡波姆10份、2%黄原胶8份、野大豆籽提取物1份、甘油丙烯酸酯/丙烯酸共聚物0.5份;
B.辛酸/癸酸甘油三酯2份、聚二甲基硅氧烷1份、N-棕榈酰羟基脯氨酸鲸蜡酯0.3份、角鲨烷0.1份、异硬脂醇异硬脂酸酯0.5份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.2份;
C.三乙醇胺0.16份;
D.氨基丁酸0.1份;
E.(HA-TP)130-150万中分子透明质酸钠0.03份、丁二醇0.18份、(纳诺HA)3000-1万低分子透明质酸钠0.02份、棕榈酰四肽-7 0.5份、羟苯基丙酰胺苯甲酸0.15份、半胱氨酸1份、泛醇0.2份、聚季铵盐-51 0.2份、水解酵母提取物1份;
F.TAIFEX 3465香精0.012份、ALINE CO 12838香精0.01份、HONEY FLAVOURDC5023/01香精0.006份;
G.辛酰羟肟酸0.5份、苯氧乙醇0.2份;
纯化水余量。
对比例5
化妆品组合物,包含以下组分:A.尿囊素0.1份、甘草酸二钾0.1份、甜菜碱1份、聚甘油-6 2份、甘油聚醚-26 1份、甘油3份、3%卡波姆10份、2%黄原胶8份、野大豆籽提取物1份、甘油丙烯酸酯/丙烯酸共聚物0.5份;
B.辛酸/癸酸甘油三酯2份、聚二甲基硅氧烷1份、N-棕榈酰羟基脯氨酸鲸蜡酯0.3份、角鲨烷0.1份、异硬脂醇异硬脂酸酯0.5份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.2份、海茴香提取物0.1份;
C.三乙醇胺0.16份;
D.氨基丁酸0.1份;
E.(HA-TP)130-150万中分子透明质酸钠0.03份、丁二醇0.18份、(纳诺HA)3000-1万低分子透明质酸钠0.02份、棕榈酰四肽-7 0.5份、羟苯基丙酰胺苯甲酸0.15份、半胱氨酸1份、泛醇0.2份、聚季铵盐-51 0.2份;
F.TAIFEX 3465香精0.012份、ALINE CO 12838香精0.01份、HONEY FLAVOURDC5023/01香精0.006份;
G.辛酰羟肟酸0.5份、苯氧乙醇0.2份;
纯化水余量。
对比例6
含益生元的化妆品组合物,包含以下组分:
A.尿囊素0.1份、甘草酸二钾0.1份、甜菜碱1份、聚甘油-6 2份、甘油聚醚-26 1份、甘油3份、3%卡波姆10份、2%黄原胶8份、野大豆籽提取物1份、甘油丙烯酸酯/丙烯酸共聚物0.5份;
B.辛酸/癸酸甘油三酯2份、聚二甲基硅氧烷1份、N-棕榈酰羟基脯氨酸鲸蜡酯0.3份、角鲨烷0.1份、异硬脂醇异硬脂酸酯0.5份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.2份、海茴香提取物0.1份;
C.三乙醇胺0.16份;
D.氨基丁酸0.1份;
E.(HA-TP)130-150万中分子透明质酸钠0.03份、丁二醇0.18份、(纳诺HA)3000-1万低分子透明质酸钠0.02份、羟苯基丙酰胺苯甲酸0.15份、半胱氨酸1份、泛醇0.2份、聚季铵盐-51 0.2份、水解酵母提取物1份;
F.TAIFEX 3465香精0.012份、ALINE CO 12838香精0.01份、HONEY FLAVOURDC5023/01香精0.006份;
G.辛酰羟肟酸0.5份、苯氧乙醇0.2份;
纯化水余量。
对以上实施例和对比例做进一步效果检测。
测定本发明实施例1和对比例的抗氧活性(AOA),AOA表示滴定100g所分析的物质消耗的库仑量,如表2。
表2
测定皮肤肤色L值,使用德国Courage Khazaka(CK)公司生产的皮肤颜色测试仪Colorimeter CL400,通过测量产品使用前后皮肤L值的变化,评估其对皮肤透亮度的影响,对起始L值平均值相同的三组受试者进行检测,每组10人,周期为4周,结果取平均值,如表3。
表3
测定皮肤水合度,使三组受试者的起始平均值相同,每组10人,周期为四周,结果取平均值,如表4。
表4
实施例1 | 实施例2 | 实施例3 | 实施例4 | 实施例5 | 实施例6 | ||
0周 | 22.9 | 23.7 | 23.6 | 23.4 | 23.2 | 22.9 | |
4周 | 33.2 | 33.5 | 35.2 | 35.5 | 35.7 | 35.9 | |
对比例1 | 对比例2 | 对比例3 | 对比例4 | 对比例5 | 对比例6 | 对比例7 | |
0周 | 23.0 | 23.2 | 23.3 | 23.0 | 22.9 | 22.6 | 21.7 |
4周 | 31.5 | 32.2 | 32.5 | 30.8 | 30.4 | 29.7 | 30.3 |
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。
Claims (10)
1.一种含益生元的化妆品组合物,其特征在于,包含以下组分:
A.尿囊素、甘草酸二钾、甜菜碱、聚甘油、甘油聚醚、甘油、卡波姆、黄原胶、野大豆籽提取物、甘油丙烯酸酯/丙烯酸共聚物;
B.辛酸/癸酸甘油三酯、聚二甲基硅氧烷、N-棕榈酰羟基脯氨酸鲸蜡酯、角鲨烷、异硬脂醇异硬脂酸酯、植物甾醇/辛基十二醇月桂酰谷氨酸酯、海茴香提取物;
C.三乙醇胺;
D.氨基丁酸;
E.透明质酸钠、丁二醇、透明质酸钠、棕榈酰四肽-7、羟苯基丙酰胺苯甲酸、半胱氨酸、泛醇、聚季铵盐-51、水解酵母提取物;
F.香精;
G.辛酰羟肟酸、苯氧乙醇。
2.根据权利要求1所述的含益生元的化妆品组合物,其特征在于,还包括水。
3.根据权利要求1所述的含益生元的化妆品组合物,其特征在于,包含以下重量份的组分:
A.尿囊素0.05~0.3份、甘草酸二钾0.05~0.3份、甜菜碱0.5~3份、聚甘油1~4份、甘油聚醚0.5~3份、甘油2~5份、卡波姆8~13份、黄原胶6~10份、野大豆籽提取物0.5~2.5份、甘油丙烯酸酯/丙烯酸共聚物0.2~1份;
B.辛酸/癸酸甘油三酯1~5份、聚二甲基硅氧烷0.5~3.5份、N-棕榈酰羟基脯氨酸鲸蜡酯0.1~1.5份、角鲨烷0.1~1份、异硬脂醇异硬脂酸酯0.2~0.9份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.1~1.5份、海茴香提取物0.1~1份;
C.三乙醇胺0.1~0.5份;
D.氨基丁酸0.05~0.85份;
E.透明质酸钠0.01~0.09份、丁二醇0.1~0.4份、透明质酸钠0.01~0.06份、棕榈酰四肽-7 0.1~0.9份、羟苯基丙酰胺苯甲酸0.1~0.6份、半胱氨酸0.5~3份、泛醇0.1~1份、聚季铵盐-51 0.1~0.8份、水解酵母提取物0.5~2份;
F.香精0.018~0.058份;
G.辛酰羟肟酸0.1~0.8份、苯氧乙醇0.1~0.5份。
4.根据权利要求3所述的含益生元的化妆品组合物,其特征在于,包含以下重量份的组分:
A.尿囊素0.05~0.15份、甘草酸二钾0.05~0.25份、甜菜碱1~2份、聚甘油1~3份、甘油聚醚0.5~1.5份、甘油2~3份、卡波姆8~10份、黄原胶6~8份、野大豆籽提取物0.5~1.5份、甘油丙烯酸酯/丙烯酸共聚物0.5~1份;
B.辛酸/癸酸甘油三酯1~2份、聚二甲基硅氧烷0.5~1.5份、N-棕榈酰羟基脯氨酸鲸蜡酯0.3~0.9份、角鲨烷0.1~0.5份、异硬脂醇异硬脂酸酯0.2~0.5份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.1~0.2份、海茴香提取物0.1~0.5份;
C.三乙醇胺0.16~0.36份;
D.氨基丁酸0.1~0.3份;
E.透明质酸钠0.01~0.03份、丁二醇0.18~0.28份、透明质酸钠0.01~0.03份、棕榈酰四肽-7 0.1~0.5份、羟苯基丙酰胺苯甲酸0.15~0.35份、半胱氨酸0.5~1份、泛醇0.1~0.2份、聚季铵盐-51 0.1~0.3份、水解酵母提取物0.5~1份;
F.香精0.018~0.028份;
G.辛酰羟肟酸0.1~0.5份、苯氧乙醇0.1~0.2份。
5.根据权利要求4所述的含益生元的化妆品组合物,其特征在于,包含以下重量份的组分:
A.尿囊素0.1份、甘草酸二钾0.1份、甜菜碱1份、聚甘油2份、甘油聚醚1份、甘油3份、卡波姆10份、黄原胶8份、野大豆籽提取物1份、甘油丙烯酸酯/丙烯酸共聚物0.5份;
B.辛酸/癸酸甘油三酯2份、聚二甲基硅氧烷1份、N-棕榈酰羟基脯氨酸鲸蜡酯0.3份、角鲨烷0.1份、异硬脂醇异硬脂酸酯0.5份、植物甾醇/辛基十二醇月桂酰谷氨酸酯0.2份、海茴香提取物0.1份;
C.三乙醇胺0.16份;
D.氨基丁酸0.1份;
E.透明质酸钠0.03份、丁二醇0.18份、透明质酸钠0.02份、棕榈酰四肽-7 0.5份、羟苯基丙酰胺苯甲酸0.15份、半胱氨酸1份、泛醇0.2份、聚季铵盐-51 0.2份、水解酵母提取物1份;
F.香精0.028份;
G.辛酰羟肟酸0.5份、苯氧乙醇0.2份。
6.根据权利要求1~5任一项所述的含益生元的化妆品组合物,其特征在于,A组分所述聚甘油为聚甘油-6。
7.根据权利要求1~5任一项所述的含益生元的化妆品组合物,其特征在于,A组分所述甘油聚醚为甘油聚醚-26。
8.根据权利要求1~5任一项所述的含益生元的化妆品组合物,其特征在于,A组分所述卡波姆为2~3%卡波姆;所述黄原胶为2~3%黄原胶。
9.根据权利要求1~5任一项所述的含益生元的化妆品组合物,其特征在于,F组分所述香精包括TAIFEX 3465香精、ALINE CO 12838香精和HONEY FLAVOUR DC5023/01香精。
10.权利要求1~9任一所述含益生元的化妆品组合物的制备方法,其特征在于,包括以下步骤:按照任一所述组分进行称取,并分别混合成A、B、C、D、E、F和G组分,搅拌混匀,出料,即可得到含益生元的化妆品组合物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010305309.7A CN111557892A (zh) | 2020-04-17 | 2020-04-17 | 含益生元的化妆品组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010305309.7A CN111557892A (zh) | 2020-04-17 | 2020-04-17 | 含益生元的化妆品组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111557892A true CN111557892A (zh) | 2020-08-21 |
Family
ID=72074423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010305309.7A Pending CN111557892A (zh) | 2020-04-17 | 2020-04-17 | 含益生元的化妆品组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111557892A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115154355A (zh) * | 2022-07-19 | 2022-10-11 | 广州东森医药科技有限公司 | 一种富含胶原的组合物及其制备方法与应用 |
CN115414298A (zh) * | 2022-09-29 | 2022-12-02 | 广州环亚化妆品科技股份有限公司 | 一种促渗组合物及其制备方法和应用 |
FR3130146A1 (fr) * | 2021-12-10 | 2023-06-16 | L'oreal | Composition comprenant de la cystéine, un triglycéride d’acide gras particulier et un agent réducteur supplémentaire |
-
2020
- 2020-04-17 CN CN202010305309.7A patent/CN111557892A/zh active Pending
Non-Patent Citations (1)
Title |
---|
安婕妤化妆品科技股份有限公司: "菲莎妮丝海之秘龄精华液", 《国产非特殊用途化妆品备案信息服务平台》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3130146A1 (fr) * | 2021-12-10 | 2023-06-16 | L'oreal | Composition comprenant de la cystéine, un triglycéride d’acide gras particulier et un agent réducteur supplémentaire |
CN115154355A (zh) * | 2022-07-19 | 2022-10-11 | 广州东森医药科技有限公司 | 一种富含胶原的组合物及其制备方法与应用 |
CN115154355B (zh) * | 2022-07-19 | 2024-05-28 | 广州东森医药科技有限公司 | 一种富含胶原的组合物及其制备方法与应用 |
CN115414298A (zh) * | 2022-09-29 | 2022-12-02 | 广州环亚化妆品科技股份有限公司 | 一种促渗组合物及其制备方法和应用 |
CN115414298B (zh) * | 2022-09-29 | 2023-09-26 | 广州环亚化妆品科技股份有限公司 | 一种促渗组合物及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2749750C (en) | Skin care compositions and methods of use thereof | |
CN111557892A (zh) | 含益生元的化妆品组合物 | |
KR102265730B1 (ko) | 피부 주름 개선 및 미백용 화장료 조성물 | |
CN110638709A (zh) | 一种抗蓝光的多效修护眼霜及其制备方法 | |
CN109453087B (zh) | 美白透肌水及其制备方法和美白化妆品添加剂 | |
CN109431908B (zh) | 美白保湿霜及其制备方法和美白化妆品添加剂 | |
CN112120986A (zh) | 一种眼部修护组合物及含有该组合物的眼霜 | |
CN109330954B (zh) | 美白亮肤水及其制备方法和酪氨酸酶抑制剂 | |
CN109453059B (zh) | 美白化妆品添加剂和美白睡眠面膜及其制备方法 | |
CN110946784A (zh) | 一种具有提升皮肤屏障功能、加强皮肤健康的护肤组合物 | |
CN111467271A (zh) | 一种含乙酰化透明质酸的护肤品 | |
CN112603870A (zh) | 一种多效精华霜及其制备方法 | |
US20220387276A1 (en) | Composition Comprising Oils, Free Fatty Acids And Squalene | |
KR101254330B1 (ko) | 눈가 주름 개선용 화장료 조성물 | |
JP2004091376A (ja) | 表皮角化正常化剤及びこれを含有する皮膚外用剤 | |
CN110787074A (zh) | 一种淡化细纹的组合物 | |
CN112353705B (zh) | 化妆品组合物及其制备方法和具有祛皱、延缓衰老功效的化妆品 | |
EP3043770B1 (en) | Cosmetic compositions containing a combination of natural active ingredients | |
CN113081942A (zh) | 一种含有苹果干细胞的多维水合霜 | |
CN109528589B (zh) | 酪氨酸酶抑制剂和美白修护霜及其制备方法 | |
CN109453088B (zh) | 美白紧致霜及其制备方法和酪氨酸酶抑制剂 | |
CN108653088B (zh) | 一种水漾丝滑润泽霜 | |
CN113893199B (zh) | 一种具有增加皮肤厚度功效的面霜组合物及其制备方法 | |
WO2011113785A2 (en) | A cosmetic composition for rejuvenating skin appearance | |
CN115089537A (zh) | 一种深度修护精华液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200821 |